Why listen
Find out why accrediting psychedelic therapy education is harder than it should be and what is at stake.
0:00––:––
Enjoy the episode?
Subscribe to The Psychedelic Report
Listen & subscribe on
In this episode
- What Psychedelic Support offers clinicians working with MDMA, psilocybin, and ketamine
- Why ACCME accreditation for psychedelic courses remains a real obstacle
- How the FDA and DEA are sending conflicting signals on ketamine treatment
- How equine therapy is finding a place alongside psychedelic-assisted care
About this episode
Is the field of psychedelic therapy receiving the educational support it needs? In this episode, Dr. Dave Rabin engages in a thought-provoking conversation with Dr. Allison Feduccia, a neuropharmacologist and the founder of Psychedelic Support. They explore the organization's mission, which includes providing crucial resources, a directory of licensed health professionals, and ACCME-accredited online courses covering substances like MDMA, psilocybin, and ketamine. The episode sheds light on the hurdles Psychedelic Support faces in obtaining ACCME accreditation for their courses, raising concerns about the impact on education accessibility. The dialogue encompasses the FDA's warning on ketamine treatments, its contradictory extension through telehealth by the DEA, and Dr. Allison Feduccia's personal journey with ayahuasca, leading to her involvement in equine facilitated services and the development of a course on equine therapy. As they discuss the potential changes in accreditation, Dr. Allison emphasizes the significance of clinicians taking these courses and supporting organizations like Psychedelic Support in advancing psychedelic therapy education.Web: https://psychedelic.support/
ACCME Web:https://www.accme.org/
https://www.instagram.com/accreditedcme
Contact number: (312) 527-9200
Twitter: https://twitter.com/DrDavidRabin
Instagram: https://www.instagram.com/drdavidrabin
Web: https://www.drdave.io/
Learn more about your ad choices. Visit megaphone.fm/adchoices
About The Psychedelic Report
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr.
See all episodes →
